ACELYRIN

ACELYRIN is a biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of promising drug candidates, leveraging its expertise to rapidly bring these drugs to patients and provide them with life-changing new therapeutic options. The company’s product, Izokibep, is a unique antibody mimetic interleukin-17A (IL-17A) inhibitor designed to overcome the limitations of monoclonal antibodies.